TRANSLATE-TIMI 70

TRANSLATE-TIMI 70 is a phase 2b trial testing multiple doses of vupanorsen, an antisense oligonucleotide (ASO) against angiopoietin-like 3 (ANGPTL3) mRNA, for safety and efficacy in non-HDL-C lowering. MAIN RESULTS: Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70 Circulation. 2022 May 3;145(18):1377-1386. PRESENTATIONS TRANSLATE Main Results (Bergmark … Continue reading TRANSLATE-TIMI 70